BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2448461)

  • 1. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model.
    Vuopio-Varkila J; Karvonen M; Saxén H
    J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli peritonitis in immunosuppressed mice: the role of specific and non-specific immunity.
    Vuopio-Varkila J
    J Med Microbiol; 1988 Jan; 25(1):33-9. PubMed ID: 3275782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.
    Schiff DE; Wass CA; Cryz SJ; Cross AS; Kim KS
    Infect Immun; 1993 Mar; 61(3):975-80. PubMed ID: 7679376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
    Kariyawasam S; Wilkie BN; Gyles CL
    Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing of Escherichia coli in the peritoneal cavity of convalescent mice; role of specific and non-specific immune mechanisms.
    Vuopio-Varkila J; Mäkelä PH
    J Med Microbiol; 1988 Mar; 25(3):205-11. PubMed ID: 3126298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
    Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
    Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
    Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
    Sakulramrung R; Domingue GJ
    J Infect Dis; 1985 Jun; 151(6):995-1004. PubMed ID: 3889175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.
    Valentine CH; Hellman J; Beasley-Topliffe LK; Bagchi A; Warren HS
    Mol Med; 2006; 12(9-10):252-8. PubMed ID: 17225874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Durant L; Metais A; Soulama-Mouze C; Genevard JM; Nassif X; Escaich S
    Infect Immun; 2007 Apr; 75(4):1916-25. PubMed ID: 17145948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
    J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Mellata M; Mitchell NM; Schödel F; Curtiss R; Pier GB
    Vaccine; 2016 Jan; 34(5):656-662. PubMed ID: 26707217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.
    Smith HW; Huggins MB
    J Gen Microbiol; 1980 Dec; 121(2):387-400. PubMed ID: 7021764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.
    Pluschke G; Achtman M
    Infect Immun; 1985 Aug; 49(2):365-70. PubMed ID: 2410365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens.
    Ahrén CM; Svennerholm AM
    Infect Immun; 1982 Oct; 38(1):74-9. PubMed ID: 6754618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.